Table 1.
Clinicopathological characteristics | n | Low expression | High expression | P value |
---|---|---|---|---|
Total | 108 | 54 | 54 | |
Gender | 0.060 | |||
Male | 75 | 33 | 42 | |
Female | 33 | 21 | 12 | |
Age (years) | 0.440 | |||
≤ 60 | 83 | 41 | 42 | |
> 60 | 25 | 13 | 12 | |
Grade of differentiation | 0.123 | |||
Low | 56 | 32 | 24 | |
High-Middle | 52 | 22 | 30 | |
Tumor diameter (cm) | 0.123 | |||
≤ 5 | 50 | 29 | 21 | |
> 5 | 58 | 25 | 33 | |
Liver function (Child-Pugh stage) | 0.588 | |||
A | 92 | 45 | 47 | |
B or C | 16 | 9 | 7 | |
Hepatocirrhosis | 0.288 | |||
Absent | 31 | 13 | 18 | |
Present | 77 | 41 | 36 | |
HBV infection | 0.555 | |||
Absent | 43 | 20 | 23 | |
Present | 65 | 34 | 31 | |
Thrombosis of tumor blood vessel | 0.011 | |||
Absent | 65 | 26 | 39 | |
Present | 43 | 28 | 15 | |
AFP (ng/ml) | 0.083 | |||
≤ 20 | 53 | 22 | 31 | |
> 20 | 55 | 32 | 23 | |
BCLC stage | 0.552 | |||
A | 41 | 19 | 22 | |
B, C, or D | 67 | 35 | 32 | |
Envelope | 0.700 | |||
Absent | 52 | 25 | 27 | |
Present | 56 | 29 | 27 | |
Tumor satellite | 0.079 | |||
Absent | 63 | 27 | 36 | |
Present | 45 | 27 | 18 | |
MVD | < 0.001 | |||
High | 59 | 45 | 14 | |
Low | 49 | 9 | 40 |
AFP serum alpha fetoprotein, HBV hepatitis B virus, BCLC Barcelona Clinic Liver Cancer